GW Pharmaceuticals plc Overview
Company Headquarter: Cambridge, UK
Founded: 1998
Workforce: ~1000
Company Working: GW Pharmaceuticals plc is a world leader in the development of plant-derived cannabinoid therapeutics. The company has a strong presence in the UK and the US. It also has a presence in the EU5 countries (France, Germany, Italy, Spain, and the UK), the Netherlands, and Switzerland, among others. It has ties with leading cannabinoid scientists across the globe. It offers a wide range of novel cannabinoid molecules in several distinct therapeutic areas, including autism, epilepsy, and schizophrenia. The company is focusing on offering cannabinoid-based prescription medicines to patients. In May 2021, GW Pharmaceuticals plc became subsidiary of Jazz Pharmaceuticals (Ireland), a leader in the science, development, and commercialization of cannabinoid-based prescription medicines.
Strategy
GW Pharmaceuticals plc focuses on developing life-changing medicines for severe diseases that have limited or no therapeutic options. It is working with cannabinoid scientists around the globe to develop advanced products. It is making various partnerships in the region for future growth. Furthermore, the corporation works aggressively with other companies to incorporate advances and expand product reach.
